Study for serum estrogen concentration during aromatase inhibitor treatment

Study for serum estrogen concentration during aromatase inhibitor treatment - Serum E2 study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013264

Enrollment

Registered

2014-02-25

Start date

2014-02-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Breast cancer patients treated with AI as adjuvant therapy

Exclusion criteria

Exclusion criteria: Concurrent endocrine treatment other than AI

Design outcomes

Primary

Measure	Time frame
Serum E2 level on aromatase inhibitor	—

Countries

Japan

Contacts

Public ContactMoe Tsuda

Graduate School of Medicine Kyoto University Department of Breast Surgery

moe1985@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results